Eagle Strategies’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Eagle Strategies's PFE Position: Q3 2026 in Review
Eagle Strategies increased its Pfizer (PFE) stake by 1% in Q3 2026, buying an estimated $3.75K and bringing the position to 13,697 shares worth $391K. The position accounts for 0.04% of the portfolio, ranked #210.
Eagle Strategies first reported a position in PFE in Q4 2021 and has held it in 20 quarters since. The position peaked at $540K in Q4 2021. 1,743 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Eagle Strategies held 13,697 shares of Pfizer worth $391K as of Q3 2026.
- Eagle Strategies bought 141 Pfizer shares in Q3 2026, an estimated $3.75K.
- Pfizer made up 0.04% of Eagle Strategies's portfolio in Q3 2026, its #210 holding.
- Eagle Strategies first reported a position in Pfizer in Q4 2021 and has held it in 20 quarters since.
- Eagle Strategies's Pfizer position peaked at $540K in Q4 2021.
- 1,743 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Eagle Strategies's 13F filing for Q3 2026, filed 16 Oct 2026.